Showing results (71-80 of 2,635) with videos related to

Sort By:
Pageof 264
Hematology (Amsterdam, Netherlands)|October 22, 2021
miR-149-3p suppressed epithelial-mesenchymal transition and tumor development in acute myeloid leukemiaYaoyao Tian, Yongfang Jiang, Xiushuai Dong, et al.
Hematology (Amsterdam, Netherlands)|February 8, 2022
Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case seriesFaouzi Djebbari, Matt Poynton, Gina Sangha, et al.
Hematology (Amsterdam, Netherlands)|February 14, 2022
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trialHiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, et al.
Hematology (Amsterdam, Netherlands)|January 24, 2022
Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in JapanTerumi Baba, Yoshinori Hashimoto, Hajime Yasuda, et al.
Hematology (Amsterdam, Netherlands)|January 24, 2022
Clinical characteristics of 512 eculizumab-naive paroxysmal nocturnal hemoglobinuria patients in China: a single-center observational studyYali Du, Yuan Yang, Chen Yang, et al.
Hematology (Amsterdam, Netherlands)|January 24, 2022
Molecular epidemiological investigation of abnormal hemoglobin in Shaokwan region, southern ChinaHui Yang, Min Lin, Fen Lin, et al.
Hematology (Amsterdam, Netherlands)|April 18, 2022
Attitudes and practices of unmarried adults towards sickle cell disease: emergent factors from a cross sectional study in Nigeria's capitalObi Peter Adigwe, Godspower Onavbavba, Solomon Oloche Onoja
Hematology (Amsterdam, Netherlands)|April 27, 2022
Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogeneticsXin Xiang, Qiongyu Lu, Xiaoyu Xu, et al.
Hematology (Amsterdam, Netherlands)|February 28, 2022
Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the treatment of acute myeloid leukemia: a systematic meta-analysisJun Li, Xiaoping Yin
Hematology (Amsterdam, Netherlands)|February 28, 2022
Encouraging the outcomes of children with beta-thalassaemia major who underwent fresh cord blood transplantation from an HLA-matched sibling donorJianyun Wen, Xiaodong Wang, Libai Chen, et al.
Pageof 264